DENTSPLY SIRONA is emerging from a period of severe operational and balance-sheet stress, with 2026Q2 showing a rebound to 54.9% gross margin and positive net income of $37M, yet revenue contracted 4.1% year-over-year to $898M, indicating demand remains weak.
Price trend, volume and key moving averages
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | $0.29-6.1% vs $0.31 | $836M-3.0% vs $862M |
Q3 2026 Aug 6, 2026 | $0.52+49.4% vs $0.35 | $898M+0.9% vs $890M |
Q2 2026 May 5, 2026 | $0.27-3.6% vs $0.28 | $880M+4.5% vs $842M |
Q1 2026 Feb 26, 2026 | $0.27-3.6% vs $0.28 | $961M+3.8% vs $926M |
DENTSPLY SIRONA NASDAQ: XRAY lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle East conflict and higher freight costs offset progress in parts of its U.S. operations.
DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Dentsply International (XRAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.37 per share a year ago.
Benchmark XRAY against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for DENTSPLY SIRONA Inc. (XRAY)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.46 | $1.9B | -15.57 | -2.98% | -3.38% | -9.02% | 6.79% | |
| $166.00 | $11.89B | 23.97 | 0.9% | 11.83% | 11.76% | — | |
| $86.05 | $9.8B | 23.00 | 4.03% | 3.07% | 8.83% | — | |
| $25.17 | $4.1B | 6.49 | 8.32% | 22.01% | 20.52% | — | |
| $87.23 | $5.2B | 32.89 | 11.66% | 9.94% | 9.65% | — | |
| $51.50 | $1.54B | 21.13 | 5.16% | 5.36% | 7.07% | 1.54% |
DENTSPLY SIRONA Inc. (XRAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
DENTSPLY SIRONA Inc. (XRAY) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jun 11, 2026·SEC
Jun 4, 2026·SEC
Get notified when XRAY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DENTSPLY SIRONA Inc. (XRAY) stock FAQ — growth, dividends, profitability & financials explained
DENTSPLY SIRONA Inc. (XRAY) reported $3.58B in revenue over the trailing twelve months. Revenue was $3.68B in fiscal year 2025. That is 460% more than the $656.6M of fiscal year 1996.
DENTSPLY SIRONA Inc. (XRAY) revenue fell by 1.4% over the trailing twelve months, compared with the twelve months before.
No. DENTSPLY SIRONA Inc. (XRAY) reported a net loss of $121.0M over the trailing twelve months.
Yes. DENTSPLY SIRONA Inc. (XRAY) pays a dividend that yields 6.79% at the current price, a high yield.
DENTSPLY SIRONA Inc. (XRAY) had a return on equity (ROE) of -9.0% over the trailing twelve months. A negative ROE means the company lost money over the period.
DENTSPLY SIRONA Inc. (XRAY) generated $103.0M in free cash flow over the trailing twelve months.
